Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
1,093.811,096.521,100.221,091.51
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
608.77608.77612.97608.77
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
1,254.811,253.011,253.871,226.33
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
1,761.111,764.271,766.881,744.71
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
642.58644.87648.48640.18
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
851.13855.66858.75845.56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
217.98217.98218.65216.88
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
3,211.833,227.213,268.383,226.55
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
948.98948.58957.83941.97
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
1,474.521,479.031,481.041,466.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
2,392.122,396.952,421.222,382.32
Q1 2026 earnings • released • EPS beat +13.15% • Revenue beat +2.77%
See results
MRK:NYSE
Merck & Co Inc
US$112.16
+2.73%
(+2.98) 1D
US$112.15
-0.01% (-0.0094)
After hours
Closed: 1 મે, 04:00:34 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRK...
ખોલો
US$112.33
High
US$114.54
Low
US$111.88
Mkt. cap
૨.૭૭ નિખર્વ
Volume
૧.૨૦ કરોડ
Dividend
૩.૦૩%
Quarterly dividend
US$0.85
Ex dividend date
16 માર્ચ, 2026
P/E ratio
૩૧.૫૬
52-wk high
US$125.14
52-wk low
US$73.31
EPS
US$3.55
Beta
૦.૨૭
Shares outstanding
૨.૪૭ અબજ
No. of employees
૭૪ હજાર
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
23 કલાક પહેલાં
A Look At Merck (MRK) Valuation After Q1 Beat And Higher 2026 Guidance
પ્રોફાઇલ
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
About Merck & Co Inc
CEOરોબર્ટ એમ. ડેવિસ
Employees74 હજાર
Founded1 જાન્યુ, 1891
Headquarters-
Sector-
Websitemerck.com
Last report
30 એપ્રિલ, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-૧.૨૮/ (-૧.૪૭ est.)USD
+13.15%beat
Revenue / Estimate
૧૬.૨૯ અબજ/ (૧૫.૮૫ અબજ est.)USD
+2.77%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
જૂન 2025
સપ્ટે 2025
ડિસે 2025
માર્ચ 2026
Revenue
15.81 અબજ
17.28 અબજ
16.40 અબજ
16.29 અબજ
Cost of goods sold
3.39 અબજ
3.74 અબજ
4.30 અબજ
3.96 અબજ
Cost of revenue
3.39 અબજ
3.74 અબજ
4.30 અબજ
3.96 અબજ
Research and development expenses
4.00 અબજ
4.00 અબજ
4.00 અબજ
3.56 અબજ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.50 અબજ
2.48 અબજ
2.73 અબજ
2.67 અબજ
Operating expense
6.49 અબજ
6.48 અબજ
6.73 અબજ
6.12 અબજ
Total operating expenses
9.88 અબજ
10.23 અબજ
11.02 અબજ
10.08 અબજ
Operating income
5.92 અબજ
7.05 અબજ
5.38 અબજ
-2.90 અબજ
Other non operating income
6.90 કરોડ
-
4.10 કરોડ
4.20 કરોડ
EBT including unusual items
5.00 અબજ
6.74 અબજ
3.42 અબજ
-3.53 અબજ
EBT excluding unusual items
5.68 અબજ
6.76 અબજ
4.98 અબજ
5.76 અબજ
Income tax expense
57.10 કરોડ
95.80 કરોડ
45.80 કરોડ
70.90 કરોડ
Effective tax rate
11.42%
14.20%
13.39%
-20.06%
Other operating expenses
-
-
-
-
Net income
4.43 અબજ
5.78 અબજ
2.96 અબજ
-4.24 અબજ
Net profit margin
28.01%
33.49%
18.07%
-26.03%
Earnings per share
2.13
2.58
2.04
-1.28
Interest and investment income
6.90 કરોડ
9.60 કરોડ
6.90 કરોડ
-
Interest expense
-30.50 કરોડ
-32.70 કરોડ
-41.10 કરોડ
-
Net interest expenses
-23.60 કરોડ
-23.10 કરોડ
-34.20 કરોડ
-
Depreciation and amortization charges
-
-
-
-
EBITDA
6.99 અબજ
8.15 અબજ
6.79 અબજ
7.36 અબજ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more